Skip to main content

Table 3 Patients’ conditions after discharge in the EIS and control groups

From: Endoscopic injection sclerotherapy for treating recurrent bleeding of small bowel angioectasias

Variables

Control group (n = 35)

EIS group (n = 31)

P-value

Re-bleeding, n (%)

21 (60.00)

7 (22.58)

0.002*

Re-admission, n (%)

21 (60.00)

4 (12.90)

< 0.001*

RBC transfusion, n (%)

14 (40.00)

3 (9.68)

0.005*

  1. NOTE: *: Compared with the control group, P < 0.05 was considered of significant difference
  2. Abbreviations: EIS, endoscopic injection sclerotherapy; RBC, red blood cell
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us